MCB-613-DataSheet-生命科學(xué)試劑-MedChemExpress_第1頁(yè)
MCB-613-DataSheet-生命科學(xué)試劑-MedChemExpress_第2頁(yè)
MCB-613-DataSheet-生命科學(xué)試劑-MedChemExpress_第3頁(yè)
MCB-613-DataSheet-生命科學(xué)試劑-MedChemExpress_第4頁(yè)
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEMCB-613Cat. No.: HY-19625CAS No.: 1162656-22-5分式: CHNO分量: 304.39作靶點(diǎn): Others作通路: Others儲(chǔ)存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 50 mg/mL (164.26 mM; Need ultrasonic)H2O : 40% PEG300 5

2、% Tween-80 45% salineSolubility: 2.5 mg/mL (8.21 mM); Clear solution2. 請(qǐng)依序添加每種溶劑: 10% DMSO 90% (20% SBE-CD in saline)Solubility: 2.5 mg/mL (8.21 mM); Clear solution3. 請(qǐng)依序添加每種溶劑: 10% DMSO 90% corn oil1/3 Master of Small Molecules 您邊的抑制劑師www.MedChemESolubility: 2.5 mg/mL (8.21 mM); Clear solutionBIOLO

3、GICAL ACTIVITY物活性 MCB-613種有效的類 醇受體共激活因 (SRC) 分“刺激物” (SMS),超刺激 SRCs 的轉(zhuǎn)錄活性。MCB-613 增加了 SRC 與其他共激活因的相互作,并顯 誘導(dǎo) ER 應(yīng)激與活性氧 (ROS) 的產(chǎn)相結(jié)合。MCB-613 種 SMS,通過(guò)過(guò)度刺激 SRC 致癌程序,靶向癌 因作抗癌藥物。體外研究 MCB-613 (6-8 M; 24 hours) activates endogenous MMP13 mRNA expression in MDA-MB-231 cells1.MCB-613 (2-10 M; 4 hours) leads to

4、proteasome dysfunction and ER stress, the induction of the markersfor unfolded protein response (UPR), including the phosphorylation of eIF2 and IRE1 as well as theinduction of ATF4 protein expression 1.MCB-613 (0-7 M; 4 hours) affects SRC-3 KO and WT HeLa cellviability, SRC-3 WT HeLa cell is more a

5、ffected by MCB-613 compared with KO cells 1.RT-PCR 1Cell Line: MDA-MB-231 cellsConcentration: 6 M; 8 MIncubation Time: 24 hoursResult: Increased MMP13 mRNA expression.Western Blot Analysis 1Cell Line: HeLa cellsConcentration: 2 M; 4 M; 6 M; 8 M; 10 MIncubation Time: 24 hoursResult: Induced the p-eIF

6、2, p-IRE1, and ATF-4 protein expression.Cell Viability Assay 1Cell Line: SRC-3 KO and WT HeLa cellsConcentration: 3 M; 4 M; 5 M; 6 M; 7 MIncubation Time: 24 hoursResult: Decreased SRC-3 KO and WT HeLa cell viability.體內(nèi)研究MCB-613 (intravenous injection; 20 mg/kg; 3 times/week; 7 weeks) significantly a

7、nd dramatically stalls thegrowth of the tumor compared with the control group and causes no obvious animal toxicity 12/3 Master of Small Molecules 您邊的抑制劑師www.MedChemEAnimal Model: MCF-7 breast cancer mouse xenograft model (athymic nude mice by injecting MCF-7cells into mammary fat pads) 1Dosage: 20

8、mg/kgAdministration: Intravenous injection; 20 mg/kg; 3 times/week; 7 weeksResult: Inhibited tumor growth in vivo.REFERENCES1. Wang L, et al. Characterization of a Steroid Receptor Coactivator Small Molecule Stimulator that Overstimulates Cancer Cells andLeads to Cell Stress and Death. Cancer Cell. 2015 Aug 10;28(2):240-52.McePdfHeightCaution: Product has not been fully validated for medical application

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論